Showing results (1681-1690 of 3,196) with videos related to
Sort By:
Pageof 320
Translational Oncology|August 28, 2015
Characterization and Clinical Implication of Th1/Th2/Th17 Cytokines Produced from Three-Dimensionally Cultured Tumor Tissues Resected from Breast Cancer PatientsAnna Kiyomi, Masujiro Makita, Tomoko Ozeki, et al.Translational Oncology|August 28, 2015
Enhancement of the Immunostimulatory Functions of Ex Vivo-Generated Dendritic Cells from Early-Stage Colon Cancer Patients by Consecutive Exposure to Low Doses of Sequential-Kinetic-Activated IL-4 and IL-12. A Preliminary StudyElisabetta Radice, Graziella Bellone, Vincenzo MirandaTranslational Oncology|May 24, 2019
Monitoring Progression of Ductal Carcinoma In Situ Using Photoacoustics and Contrast-Enhanced UltrasoundRyan Margolis, Corinne Wessner, Maria Stanczak, et al.Translational Oncology|May 31, 2019
Comparison of the Efficacy of Stereotactic Body Radiotherapy versus Surgical Treatment for Early-Stage Non-Small Cell Lung Cancer after Propensity Score MatchingBaiqiang Dong, Jin Wang, Yujin Xu, et al.Translational Oncology|May 31, 2019
Circulating Exosomal miR-141-3p and miR-375 in Metastatic Progression of Rectal CancerSebastian Meltzer, Tonje Bjørnetrø, Lars Gustav Lyckander, et al.Translational Oncology|July 30, 2018
Expression Analysis of Platinum Sensitive and Resistant Epithelial Ovarian Cancer Patient Samples Reveals New Candidates for Targeted TherapiesK Veskimäe, M Scaravilli, W Niininen, et al.Translational Oncology|September 22, 2018
Prognostic Impact of Presurgical CA19-9 Level in Pancreatic Adenocarcinoma: A Pooled AnalysisGian Carlo Mattiucci, Alessio G Morganti, Francesco Cellini, et al.Translational Oncology|May 13, 2019
Chemically Modified Variants of Fenofibrate with Antiglioblastoma PotentialJ Stalinska, E Zimolag, N A Pianovich, et al.Translational Oncology|May 16, 2019
Activation of Pyroptotic Cell Death Pathways in Cancer: An Alternative Therapeutic ApproachKanipandian Nagarajan, Kannan Soundarapandian, Rick F Thorne, et al.Translational Oncology|July 22, 2018
CBX1 Indicates Poor Outcomes and Exerts Oncogenic Activity in Hepatocellular CarcinomaYu-Feng Yang, Ying-Hua Pan, Qiu-Hong Tian, et al.Pageof 320